AbCellera Partners with Vertex to Develop Multispecific T-Cell Engagers
VANCOUVER, British Columbia, July 29, 2026 AbCellera Biologics Inc. announced a strategic collaboration with Vertex Pharmaceuticals to research, develop,...
Multispecific Antibodies
Advertisement
Jazz and AbCellera Partner on Next-Gen Cancer Antibodies
DUBLIN, Ireland and VANCOUVER, British Columbia, June 17, 2026 Jazz Pharmaceuticals and AbCellera have announced a major strategic collaboration...
Enhanced Group Secures $50 Million Financing to Accelerate Health Platform Growth
NEW YORK, June 15, 2026 Enhanced Group Inc. has announced a $50 million strategic equity financing through a private...
Harbour BioMed and BioMap Unveil AI-Powered MegaStream TechBio Platform
CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SHANGHAI, China, June 15, 2026 Harbour BioMed and BioMap have announced a long-term strategic...
Pfizer and Innovent Forge $10.5B Global Oncology Alliance
NEW YORK, SAN FRANCISCO, and SUZHOU, China, May 28, 2026 Pfizer Inc. and Innovent Biologics have announced a landmark...
Advertisements
FDA Clears IND for CS2009 Trispecific Antibody Trial
SUZHOU, China, Feb. 15, 2026 — CStone Pharmaceuticals announced that the U.S. Food and Drug Administration has granted Investigational...
Third Arc Bio Secures $52M to Advance Antibody Pipeline
SPRING HOUSE, Pa., Feb. 4, 2026 — Clinical-stage biotechnology company Third Arc Bio announced the closing of a $52...
Advertisement
